Leptin resistance: a possible interface of inflammation and metabolism in obesity-related cardiovascular disease.

[1]  M. Reilly,et al.  Adipokines, insulin resistance, and coronary artery calcification. , 2008, Journal of the American College of Cardiology.

[2]  A. Ferrante,et al.  Obesity‐induced inflammation: a metabolic dialogue in the language of inflammation , 2007, Journal of internal medicine.

[3]  L. Barouch,et al.  Leptin signaling and obesity: cardiovascular consequences. , 2007, Circulation research.

[4]  Y. Kesäniemi,et al.  Leptin and high-sensitivity C-reactive protein and their interaction in the metabolic syndrome in middle-aged subjects. , 2007, Metabolism: clinical and experimental.

[5]  V. Somers,et al.  Leptin Induces C-Reactive Protein Expression in Vascular Endothelial Cells , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[6]  J. Manson,et al.  A prospective study of inflammatory cytokines and diabetes mellitus in a multiethnic cohort of postmenopausal women. , 2007, Archives of internal medicine.

[7]  R. Freeman,et al.  Obesity-Hypertension: Emerging Concepts in Pathophysiology and Treatment , 2007, The American journal of the medical sciences.

[8]  Liwei Lu,et al.  Role of leptin in immunity. , 2007, Cellular & molecular immunology.

[9]  Anand Rohatgi,et al.  Plasma Cytokines, Metabolic Syndrome, and Atherosclerosis in Humans , 2007, Journal of Investigative Medicine.

[10]  J. Bełtowski,et al.  Leptin and atherosclerosis. , 2006, Atherosclerosis.

[11]  Herbert Tilg,et al.  Adipocytokines: mediators linking adipose tissue, inflammation and immunity , 2006, Nature Reviews Immunology.

[12]  Yi Zhang,et al.  The role of leptin in leptin resistance and obesity , 2006, Physiology & Behavior.

[13]  Jerzy Bełtowski,et al.  Role of leptin in blood pressure regulation and arterial hypertension , 2006, Journal of hypertension.

[14]  I. Haznedaroglu,et al.  Rethinking leptin and insulin action: therapeutic opportunities for diabetes. , 2006, The international journal of biochemistry & cell biology.

[15]  K. Flegal,et al.  Prevalence of overweight and obesity in the United States, 1999-2004. , 2006, JAMA.

[16]  H. Cai,et al.  Induction of leptin resistance through direct interaction of C-reactive protein with leptin , 2006, Nature Medicine.

[17]  W. Haynes.  Role of leptin in obesity‐related hypertension , 2005, Experimental physiology.

[18]  A. Mark,et al.  Role of selective leptin resistance in diet-induced obesity hypertension. , 2005, Diabetes.

[19]  K. Cheng,et al.  Leptin resistance exacerbates diet-induced obesity and is associated with diminished maximal leptin signalling capacity in rats , 2005, Diabetologia.

[20]  G. Hansson.  Inflammation, atherosclerosis, and coronary artery disease. , 2005, The New England journal of medicine.

[21]  Jing Ma,et al.  Inflammatory markers and the risk of coronary heart disease in men and women. , 2004, The New England journal of medicine.

[22]  H. Münzberg,et al.  Region-specific leptin resistance within the hypothalamus of diet-induced obese mice. , 2004, Endocrinology.

[23]  Bruce D. Johnson,et al.  Plasma leptin and prognosis in patients with established coronary atherosclerosis. , 2004, Journal of the American College of Cardiology.

[24]  A. Localio,et al.  Plasma leptin levels are associated with coronary atherosclerosis in type 2 diabetes. , 2004, The Journal of clinical endocrinology and metabolism.

[25]  L. Weinehall,et al.  Leptin, but not adiponectin, predicts stroke in males , 2004, Journal of internal medicine.

[26]  W. Maerz,et al.  Low grade inflammation in juvenile obesity and type 1 diabetes associated with early signs of atherosclerosis. , 2004, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[27]  W. Haynes,et al.  Obesity-related hypertension: Is there a role for selective leptin resistance? , 2004, Current hypertension reports.

[28]  V. Somers,et al.  Independent Association Between Plasma Leptin and C-Reactive Protein in Healthy Humans , 2004, Circulation.

[29]  P. Scarpace,et al.  Caloric restriction reverses the deficits in leptin receptor protein and leptin signaling capacity associated with diet-induced obesity: role of leptin in the regulation of hypothalamic long-form leptin receptor expression. , 2004, The Journal of endocrinology.

[30]  M. Westerterp-Plantenga,et al.  Leptin and the proinflammatory state associated with human obesity. , 2004, The Journal of clinical endocrinology and metabolism.

[31]  R. Krauss,et al.  Phenotypic effects of leptin replacement on morbid obesity, diabetes mellitus, hypogonadism, and behavior in leptin-deficient adults. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[32]  L. Weinehall,et al.  Interactions between fibrinolysis, lipoproteins and leptin related to a first myocardial infarction , 2004, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[33]  J. Kratzsch,et al.  The soluble leptin receptor is crucial for leptin action: evidence from clinical and experimental data , 2003, International Journal of Obesity.

[34]  G. Davı̀,et al.  Leptin increase is associated with markers of the hemostatic system in obese healthy women , 2003, Journal of thrombosis and haemostasis : JTH.

[35]  C. Di Mario,et al.  Association of Insulin Resistance, Hyperleptinemia, and Impaired Nitric Oxide Release With In-Stent Restenosis in Patients Undergoing Coronary Stenting , 2003, Circulation.

[36]  E. Yeh,et al.  Inflammatory Cytokines Stimulated C-Reactive Protein Production by Human Coronary Artery Smooth Muscle Cells , 2003, Circulation.

[37]  L. Luzi,et al.  Fasting plasma leptin, tumor necrosis factor-alpha receptor 2, and monocyte chemoattracting protein 1 concentration in a population of glucose-tolerant and glucose-intolerant women: impact on cardiovascular mortality. , 2003, Diabetes care.

[38]  G. Yoshino,et al.  C-reactive protein in young, apparently healthy men: associations with serum leptin, QTc interval, and high-density lipoprotein-cholesterol. , 2003, Metabolism: clinical and experimental.

[39]  H. Oflaz,et al.  Determination of endothelial function and early atherosclerotic changes in healthy obese women. , 2003, Diabetes, nutrition & metabolism.

[40]  J. Puder,et al.  Endotoxin stimulates leptin in the human and nonhuman primate. , 2003, The Journal of clinical endocrinology and metabolism.

[41]  G. Ciliberto,et al.  High circulating levels of biologically inactive IL‐6/SIL‐6 receptor complexes in systemic juvenile idiopathic arthritis: evidence for serum factors interfering with the binding to gp130 , 2003, Clinical and experimental immunology.

[42]  Gary L Myers,et al.  Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. , 2003, Circulation.

[43]  P. Shepherd,et al.  Glucose-dependent Regulation of Cholesterol Ester Metabolism in Macrophages by Insulin and Leptin* , 2002, The Journal of Biological Chemistry.

[44]  S. Zolotukhin,et al.  Hypothalamic delivery of doxycycline-inducible leptin gene allows for reversible transgene expression and physiological responses , 2002, Gene Therapy.

[45]  Misuzu Tanaka,et al.  Relationship between changes in serum leptin levels and blood pressure after weight loss. , 2002, Hypertension research : official journal of the Japanese Society of Hypertension.

[46]  S Margetic,et al.  Leptin: a review of its peripheral actions and interactions , 2002, International Journal of Obesity.

[47]  H. Hauner,et al.  Relationship between IL-6, leptin and adiponectin and variables of fibrinolysis in overweight and obese hypertensive patients. , 2002, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[48]  N. Sattar,et al.  Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City Diabetes Study. , 2002, Diabetes care.

[49]  Graham M Lord,et al.  Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. , 2002, The Journal of clinical investigation.

[50]  J. Małyszko,et al.  Leptin Correlates with Some Hemostatic Parameters in CAPD Patients , 2002, Nephron.

[51]  A. Mark,et al.  Selective leptin resistance: a new concept in leptin physiology with cardiovascular implications. , 2002, Journal of hypertension.

[52]  R. Westrick,et al.  Effect of leptin on arterial thrombosis following vascular injury in mice. , 2002, JAMA.

[53]  B. Kennedy,et al.  Attenuation of leptin action and regulation of obesity by protein tyrosine phosphatase 1B. , 2002, Developmental cell.

[54]  S. Zolotukhin,et al.  Central leptin gene delivery evokes persistent leptin signal transduction in young and aged-obese rats but physiological responses become attenuated over time in aged-obese rats , 2002, Neuropharmacology.

[55]  M. Reitman,et al.  Leptin-replacement therapy for lipodystrophy. , 2002, The New England journal of medicine.

[56]  A. Mark,et al.  The concept of selective leptin resistance: evidence from agouti yellow obese mice. , 2002, Diabetes.

[57]  N. Sattar,et al.  Plasma Leptin and the Risk of Cardiovascular Disease in the West of Scotland Coronary Prevention Study (WOSCOPS) , 2001, Circulation.

[58]  S. Koschnick,et al.  Leptin-dependent platelet aggregation and arterial thrombosis suggests a mechanism for atherothrombotic disease in obesity. , 2001, The Journal of clinical investigation.

[59]  R. Hoffmann,et al.  Plasma leptin concentrations during extended fasting and graded glucose infusions: relationships with changes in glucose, insulin, and FFA. , 2001, The Journal of clinical endocrinology and metabolism.

[60]  E. Rimm,et al.  Plasma insulin, leptin, and soluble TNF receptors levels in relation to obesity-related atherogenic and thrombogenic cardiovascular disease risk factors among men. , 2001, Atherosclerosis.

[61]  J. Hirsch,et al.  The effects of leptin administration in non-obese human subjects. , 2001, Obesity research.

[62]  J. Manson,et al.  C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. , 2001, JAMA.

[63]  Y. Kaneda,et al.  Leptin Induces Mitochondrial Superoxide Production and Monocyte Chemoattractant Protein-1 Expression in Aortic Endothelial Cells by Increasing Fatty Acid Oxidation via Protein Kinase A* , 2001, The Journal of Biological Chemistry.

[64]  M. Matheny,et al.  Hypothalamic leptin resistance is associated with impaired leptin signal transduction in aged obese rats , 2001, Neuroscience.

[65]  P. Rizzon,et al.  Plasma leptin is independently associated with the intima-media thickness of the common carotid artery , 2001, International Journal of Obesity.

[66]  A. Lammert,et al.  Soluble leptin receptor represents the main leptin binding activity in human blood. , 2001, Biochemical and biophysical research communications.

[67]  R. Unger,et al.  Liporegulation in Diet-induced Obesity , 2001, The Journal of Biological Chemistry.

[68]  M. Pfeffer,et al.  Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction. , 2000, Circulation.

[69]  P. Ridker,et al.  Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. , 2000, Circulation.

[70]  M. Kim,et al.  Expression of leptin receptor (Ob-R) in human atherosclerotic lesions: potential role in intimal neovascularization. , 2000, Yonsei medical journal.

[71]  G. Paolisso,et al.  Plasma leptin level is associated with myocardial wall thickness in hypertensive insulin-resistant men. , 1999, Hypertension.

[72]  K. Fujioka,et al.  Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial. , 1999, JAMA.

[73]  J. Flier,et al.  The Role of SOCS-3 in Leptin Signaling and Leptin Resistance* , 1999, The Journal of Biological Chemistry.

[74]  J Licinio,et al.  Human leptin deficiency caused by a missense mutation: multiple endocrine defects, decreased sympathetic tone, and immune system dysfunction indicate new targets for leptin action, greater central than peripheral resistance to the effects of leptin, and spontaneous correction of leptin-mediated defe , 1999, The Journal of clinical endocrinology and metabolism.

[75]  T. Olsson,et al.  Leptin is associated with increased risk of myocardial infarction , 1999, Journal of internal medicine.

[76]  A. Prentice,et al.  Effects of recombinant leptin therapy in a child with congenital leptin deficiency. , 1999, The New England journal of medicine.

[77]  R. Giorgino,et al.  Plasma plasminogen activator inhibitor-I is associated with plasma leptin irrespective of body mass index, body fat mass, and plasma insulin and metabolic parameters in premenopausal women. , 1999, Metabolism: clinical and experimental.

[78]  V. Emilsson,et al.  Leptin treatment increases suppressors of cytokine signaling in central and peripheral tissues , 1999, FEBS letters.

[79]  T. Olsson,et al.  Plasma leptin levels are associated with abnormal fibrinolysis in men and postmenopausal women , 1999, Journal of internal medicine.

[80]  C. Ricordi,et al.  Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1999 by The Endocrine Society Leptin Suppression of Insulin Secretion and Gene Expression in Human Pancreatic Islets: Implications for the Development of Adipogenic Diabetes Me , 2022 .

[81]  L. Weinehall,et al.  Leptin is a risk marker for first-ever hemorrhagic stroke in a population-based cohort. , 1999, Stroke.

[82]  M. Nakata,et al.  Leptin promotes aggregation of human platelets via the long form of its receptor. , 1999, Diabetes.

[83]  T. Saruta,et al.  The obese gene product, leptin: possible role in obesity‐related hypertension in adolescents , 1998, Journal of hypertension.

[84]  J. Halaas,et al.  Leptin and the regulation of body weight in mammals , 1998, Nature.

[85]  F. Leonetti,et al.  Increased OB gene expression leads to elevated plasma leptin concentrations in patients with chronic primary hyperinsulinemia. , 1998, Diabetes.

[86]  A. Distler,et al.  Relationship between angiotensinogen, leptin and blood pressure levels in young normotensive men , 1998, Journal of hypertension.

[87]  Stephen R. Bloom,et al.  Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression , 1998, Nature.

[88]  A. McCall,et al.  Expression of leptin receptor isoforms in rat brain microvessels. , 1998, Endocrinology.

[89]  R. DeFronzo,et al.  Effect of hyperinsulinemia on plasma leptin concentrations and food intake in rats. , 1998, American journal of physiology. Endocrinology and metabolism.

[90]  C. Mantzoros,et al.  Circulating insulin concentrations, smoking, and alcohol intake are important independent predictors of leptin in young healthy men. , 1998, Obesity research.

[91]  G. Dagenais,et al.  Leptinemia Is Not a Risk Factor for Ischemic Heart Disease in Men: Prospective results from the Quebec Cardiovascular Study , 1998, Diabetes Care.

[92]  J. Flier,et al.  Identification of SOCS-3 as a potential mediator of central leptin resistance. , 1998, Molecular cell.

[93]  J. Flier,et al.  Divergent Signaling Capacities of the Long and Short Isoforms of the Leptin Receptor* , 1997, The Journal of Biological Chemistry.

[94]  N. Barzilai,et al.  Short Term Effects of Leptin on Hepatic Gluconeogenesis and in Vivo Insulin Action* , 1997, The Journal of Biological Chemistry.

[95]  Y. Miyazaki,et al.  High plasma immunoreactive leptin level in essential hypertension. , 1997, American journal of hypertension.

[96]  K. Nagashima,et al.  Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1997 by The Endocrine Society Relationship between Concentration of Serum Leptin and Fetal Growth , 1997 .

[97]  R. Burcelin,et al.  Acute stimulation of glucose metabolism in mice by leptin treatment , 1997, Nature.

[98]  S. Grüninger,et al.  Detection and quantification of the leptin receptor splice variants Ob-Ra, b, and, e in different mouse tissues. , 1997, Biochemical and biophysical research communications.

[99]  S. Kahn,et al.  Evidence That Plasma Leptin and Insulin Levels are Associated With Body Adiposity Via Different Mechanisms , 1997, Diabetes Care.

[100]  M. Polansky,et al.  Effects of prolonged hyperinsulinemia on serum leptin in normal human subjects. , 1997, The Journal of clinical investigation.

[101]  T. Olsson,et al.  Regulation of circulating leptin in humans , 1997, Endocrine.

[102]  Warren S. Alexander,et al.  A family of cytokine-inducible inhibitors of signalling , 1997, Nature.

[103]  Takaho A. Endo,et al.  A new protein containing an SH2 domain that inhibits JAK kinases , 1997, Nature.

[104]  S. Akira,et al.  Structure and function of a new STAT-induced STAT inhibitor , 1997, Nature.

[105]  J. M. Beals,et al.  Crystal structure of the obese protein Ieptin-E100 , 1997, Nature.

[106]  W. Garvey,et al.  The metabolic significance of leptin in humans: gender-based differences in relationship to adiposity, insulin sensitivity, and energy expenditure. , 1997, The Journal of clinical endocrinology and metabolism.

[107]  C. Strader,et al.  Diet-induced obese mice develop peripheral, but not central, resistance to leptin. , 1997, The Journal of clinical investigation.

[108]  W. Banks,et al.  Leptin enters the brain by a saturable system independent of insulin , 1996, Peptides.

[109]  Patricia R. Johnson,et al.  Relationship of plasma leptin to plasma insulin and adiposity in normal weight and overweight women: effects of dietary fat content and sustained weight loss. , 1996, The Journal of clinical endocrinology and metabolism.

[110]  L. Tartaglia,et al.  The full-length leptin receptor has signaling capabilities of interleukin 6-type cytokine receptors. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[111]  J. Friedman,et al.  Endotoxin and cytokines induce expression of leptin, the ob gene product, in hamsters. , 1996, The Journal of clinical investigation.

[112]  D. Porte,et al.  Cerebrospinal fluid leptin levels: Relationship to plasma levels and to adiposity in humans , 1996, Nature Medicine.

[113]  J. Friedman,et al.  Abnormal splicing of the leptin receptor in diabetic mice , 1996, Nature.

[114]  L. Tartaglia,et al.  Evidence That the Diabetes Gene Encodes the Leptin Receptor: Identification of a Mutation in the Leptin Receptor Gene in db/db Mice , 1996, Cell.

[115]  R. Considine,et al.  Serum immunoreactive-leptin concentrations in normal-weight and obese humans. , 1996, The New England journal of medicine.

[116]  Rene Devos,et al.  Identification and expression cloning of a leptin receptor, OB-R , 1995, Cell.

[117]  B. Lowell,et al.  Expression of ob mRNA and its encoded protein in rodents. Impact of nutrition and obesity. , 1995, The Journal of clinical investigation.

[118]  M. Pelleymounter,et al.  Effects of the obese gene product on body weight regulation in ob/ob mice. , 1995, Science.

[119]  R. Considine,et al.  Evidence against either a premature stop codon or the absence of obese gene mRNA in human obesity. , 1995, The Journal of clinical investigation.

[120]  M. Maffei,et al.  Positional cloning of the mouse obese gene and its human homologue , 1994, Nature.

[121]  J. Allan,et al.  Dissociation of obesity, hypercholesterolemia and diabetes from atherosclerosis in ob/ob mice , 1977, Experientia.

[122]  D. Coleman.  Effects of parabiosis of obese with diabetes and normal mice , 1973, Diabetologia.

[123]  M. Dickie,et al.  Obese, a new mutation in the house mouse. , 1950, Obesity research.

[124]  S. O’Rahilly,et al.  Is leptin an important physiological regulator of CRP? , 2007, Nature Medicine.

[125]  A. Zhao.  Is leptin an important physiological regulator of CRP? , 2007, Nature Medicine.

[126]  M. Pepys,et al.  Is leptin an important physiological regulator of CRP? , 2007, Nature Medicine.

[127]  S. Reicher,et al.  Is leptin an important physiological regulator of CRP? , 2007, Nature Medicine.

[128]  A. Siani,et al.  Plasma leptin and blood pressure in men: graded association independent of body mass and fat pattern. , 2003, Obesity research.

[129]  M. Bots,et al.  Endogenous hormones and carotid atherosclerosis in elderly men. , 2003, American journal of epidemiology.

[130]  M. Westerterp-Plantenga,et al.  The effect of pegylated recombinant human leptin (PEG-OB) on weight loss and inflammatory status in obese subjects , 2002, International Journal of Obesity.

[131]  J Licinio,et al.  Plasma leptin levels are increased in survivors of acute sepsis: associated loss of diurnal rhythm, in cortisol and leptin secretion. , 1998, The Journal of clinical endocrinology and metabolism.

[132]  N. Chinookoswong,et al.  Printed in U.S.A. Copyright © 1999 by The Endocrine Society Differential Effects of Leptin in Regulation of Tissue Glucose Utilization in Vivo* , 2022 .